FindTrial
Sign In

Geriatric Lymphoma patients: Clinicopathological profile and treatment outcome

Clinical profile, Frailty assessment and short term treatment outcome of Geriatric Lymphoma patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072169
Enrollment
84
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Interventions

Control Intervention1: nil: nil

Sponsors

MVR Cancer Centre and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients aged more than 65 years who is newly diagnosed and previously untreated lymphoid malignancies

Exclusion criteria

Exclusion criteria: ALL cases without a definite pathological diagnosis

Design outcomes

Primary

MeasureTime frame
To describe the epidemiologic, pathologic, and clinical profile of elderly patients with Lymphoma. Timepoint: At the beginning of the study—

Secondary

MeasureTime frame
To do a comprehensive geriatric assessment before initiation of treatment and assess the importance of geriatric measures, such as comorbidities and activities of daily living, in the prognosis and treatment outcome of older patients. Timepoint: before treatment—

Countries

India

Contacts

Public ContactAncy Peter

MVR Cancer Centre and Research Institute

ppnair112@gmail.com9847141122

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026